Medical device funding is reaching levels not seen since 2021, with investors pouring billions into diagnostics and imaging companies. While innovation has raced ahead, a fundamental problem remains unchanged. Critical medical hardware like MRI machines still costs millions of dollars and is largely limited to major hospitals.
This raises an important question: how can one of the most expensive, hospital-bound technologies be made available anywhere? Evan Kervella, the founder and CEO of the Paris-based startup Chipiron, recently joined the Equity podcast to discuss this problem and his vision for solving it.
Equity is TechCrunch’s flagship podcast, produced by Theresa Loconsolo. New episodes are released every Wednesday and Friday. The podcast is available on Apple Podcasts, Overcast, Spotify, and other platforms. You can also follow Equity on X and Threads at @EquityPod.